[go: up one dir, main page]

WO2009144578A3 - Composition synergique osteogenique - Google Patents

Composition synergique osteogenique Download PDF

Info

Publication number
WO2009144578A3
WO2009144578A3 PCT/IB2009/005799 IB2009005799W WO2009144578A3 WO 2009144578 A3 WO2009144578 A3 WO 2009144578A3 IB 2009005799 W IB2009005799 W IB 2009005799W WO 2009144578 A3 WO2009144578 A3 WO 2009144578A3
Authority
WO
WIPO (PCT)
Prior art keywords
synergistic
preparing
osteogenic compound
growth factor
relates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IB2009/005799
Other languages
English (en)
Other versions
WO2009144578A2 (fr
Inventor
Gérard Soula
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Adocia SAS
Original Assignee
Adocia SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adocia SAS filed Critical Adocia SAS
Publication of WO2009144578A2 publication Critical patent/WO2009144578A2/fr
Publication of WO2009144578A3 publication Critical patent/WO2009144578A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/26—Mixtures of macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412—Tissue-regenerating or healing or proliferative agents
    • A61L2300/414—Growth factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/45—Mixtures of two or more drugs, e.g. synergistic mixtures
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/02—Materials or treatment for tissue regeneration for reconstruction of bones; weight-bearing implants

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)

Abstract

L'invention concerne une composition synergique ostéogénique comprenant au moins un facteur de croissance ostéogénique, et au moins un facteur de croissance, ayant un pouvoir chémo-attractant, et angiogénique. Elle concerne également son procédé de préparation et son utilisation pour la préparation et la fabrication de produits pharmaceutiques destinés à la reconstruction ou régénération osseuse sous formes de compositions topiques par exemple implants, pâtes ou gels.
PCT/IB2009/005799 2008-05-30 2009-06-01 Composition synergique osteogenique Ceased WO2009144578A2 (fr)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US12901108P 2008-05-30 2008-05-30
US61/129,011 2008-05-30
FR08/54617 2008-07-07
FR0854617A FR2933304A1 (fr) 2008-07-07 2008-07-07 Composition synergique osteogenique
US12961808P 2008-07-08 2008-07-08
US61/129,618 2008-07-08

Publications (2)

Publication Number Publication Date
WO2009144578A2 WO2009144578A2 (fr) 2009-12-03
WO2009144578A3 true WO2009144578A3 (fr) 2010-03-11

Family

ID=40336679

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2009/005799 Ceased WO2009144578A2 (fr) 2008-05-30 2009-06-01 Composition synergique osteogenique

Country Status (3)

Country Link
US (1) US20100009911A1 (fr)
FR (1) FR2933304A1 (fr)
WO (1) WO2009144578A2 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2948573B1 (fr) * 2009-07-31 2011-11-18 Adocia Nouvelle forme d'administration de complexes de proteines osteogeniques
FR2958647B1 (fr) 2010-04-08 2013-08-23 Adocia Polysaccharides comportant des groupes fonctionnels carboxyles substitues par un derive hydrophobe porte par un spacer au moins trivalent.
US8945872B2 (en) 2013-01-25 2015-02-03 Warsaw Orthopedic, Inc. Methods of purifying human recombinant growth and differentiation factor-5 (rhGDF-5) protein
US9051389B2 (en) 2013-01-25 2015-06-09 Warsaw Orthopedic, Inc. Expression conditions and methods of human recombinant growth and differentiation factor-5 (rhGDF-5)
US8956829B2 (en) 2013-01-25 2015-02-17 Warsaw Orthopedic, Inc. Human recombinant growth and differentiaton factor-5 (rhGDF-5)
US9359417B2 (en) 2013-01-25 2016-06-07 Warsaw Orthopedic, Inc. Cell cultures and methods of human recombinant growth and differentiaton factor-5 (rhGDF-5)
US9169308B2 (en) 2013-01-25 2015-10-27 Warsaw Orthopedic, Inc. Methods and compositions of human recombinant growth and differentiation factor-5 (rhGDF-5) isolated from inclusion bodies
GB201505585D0 (en) * 2015-03-31 2015-05-13 Immatics Biotechnologies Gmbh Novel peptides and combination of peptides and scaffolds for use in immunotherapy against renal cell carinoma (RCC) and other cancers

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060084602A1 (en) * 2004-10-14 2006-04-20 Lynch Samuel E Platelet-derived growth factor compositions and methods of use thereof
WO2007116143A1 (fr) * 2006-04-07 2007-10-18 Adocia Polysaccharides bifonctionnalises
WO2008038111A1 (fr) * 2006-09-26 2008-04-03 Adocia Dextran fonctionnalise par des amino-acides hydrophobes
WO2008076671A2 (fr) * 2006-12-14 2008-06-26 Warsaw Orthopedic, Inc Implant biomédical poreux ostéogénique biodégradable à membrane imperméable

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060084602A1 (en) * 2004-10-14 2006-04-20 Lynch Samuel E Platelet-derived growth factor compositions and methods of use thereof
WO2007116143A1 (fr) * 2006-04-07 2007-10-18 Adocia Polysaccharides bifonctionnalises
WO2008038111A1 (fr) * 2006-09-26 2008-04-03 Adocia Dextran fonctionnalise par des amino-acides hydrophobes
WO2008076671A2 (fr) * 2006-12-14 2008-06-26 Warsaw Orthopedic, Inc Implant biomédical poreux ostéogénique biodégradable à membrane imperméable

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
BLANQUAERT F ET AL: "Effects of heparin-like polymers associated with growth factors on asteoblast proliferation and phenotype expression", JOURNAL OF BIOMEDICAL MATERIALS RESEARCH, WILEY, NEW YORK, NY, US, vol. 44, 1 January 1999 (1999-01-01), pages 63 - 72, XP003005696, ISSN: 0021-9304 *

Also Published As

Publication number Publication date
FR2933304A1 (fr) 2010-01-08
WO2009144578A2 (fr) 2009-12-03
US20100009911A1 (en) 2010-01-14

Similar Documents

Publication Publication Date Title
WO2009144578A3 (fr) Composition synergique osteogenique
WO2010002586A3 (fr) Compositions topiques contenant de l’isonicotinamide
WO2009101503A3 (fr) Utilisation de substances actives naturelles dans des compositions cosmétiques ou thérapeutiques
WO2009118662A3 (fr) Compositions et méthodes de traitement de la perte osseuse
WO2008113912A3 (fr) Nouvelles compositions cosmetiques et/ ou pharmaceutiques et leurs applications
WO2010072958A3 (fr) Composition pharmaceutique topique comprenant un principe actif sensible a l'eau
IL189008A (en) History of 1-Naphthalenyl-3-azabicyclo [0.1.3] hexane
WO2008073448A3 (fr) Formulations pharmaceutiques et leurs procédés de production
WO2006052451A3 (fr) Compositions de collagene implantables
WO2007034321A3 (fr) Compositions pharmaceutiques a activite cicatrisante comprenant au moins un derive de dextrane soluble et au moins un facteur de croissance derive des plaquettes
WO2013078259A3 (fr) Compositions huileuses et méthodes destinées à accroître la croissance des cheveux et/ou à prévenir la perte des cheveux
ME01394B (fr) Forme cristalline gamma-d du chlorhydrate del'ivabradine, son procédé de préparation, et les compositions pharmaceutiques qui la contiennent
EP2540301A3 (fr) Procédés et compositions pharmaceutiques servant à guérir des blessures
IL181634A (en) Topical Pharmaceuticals containing 8-pyrazolylmethyl-7,3,1-trihydroporin-6,2-wound healing treatment
WO2010012386A3 (fr) Méthode de traitement de dents hypersensibles
WO2010063673A3 (fr) Nouvelles compositions cosmétiques permettant d'inhiber la croissance pileuse
WO2011059292A3 (fr) Concentré ou extrait de pousse d'aloès officinal favorisant fortement la croissance des cellules cutanées et présentant des effets anti-allergiques et antioxydants supérieurs
WO2007123740A3 (fr) Compositions pharmaceutiques pour favoriser la cicatrisation
WO2009118726A3 (fr) Combinaison orale de vitamines
IL186062A0 (en) Indanyl-piperazine derivatives, method for preparing same and pharmaceutical compositions containing same
PT2231598E (pt) Novos derivados diazéniodiolato, processo para a sua preparação e as composições farmacêuticas que os contenham
WO2013094992A3 (fr) Utilisation du facteur de croissance pour la régénération de tissus périodontique et pulpaire endommagés d'une dent extraite, composition contenant ledit facteur de croissance en tant que principe actif, et kit de régénération tissulaire
WO2009053628A3 (fr) Nouveaux composes, préparation et utilisations
WO2009047434A3 (fr) Utilisation d'excipients en tant que conservateurs et composition pharmaceutique les comprenant
WO2008099190A3 (fr) Composés ostéogéniques

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09754206

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 09754206

Country of ref document: EP

Kind code of ref document: A2